Myofascial Pain Syndrome and Dextrose Prolotherapy
- Conditions
- Efficacy of Dextrose Prolotherapy in Myofascial Pain Syndrome
- Interventions
- Drug: Local anesthetic and saline injection to the myofascial trigger pointDrug: Injection of dextrose, local anesthetic and saline to the myofascial trigger point
- Registration Number
- NCT04941118
- Lead Sponsor
- Mustafa Kemal University
- Brief Summary
Myofascial pain syndrome is characterized by the presence of hypersensitive points called trigger points that cause pain, tenderness, spasm, stiffness, limitation of movement, weakness, taut band within the muscle, and pain reflected by pressing in a muscle group or a single muscle.
Prolotherapy is a regenerative treatment method in the treatment of chronic musculoskeletal pain, in which an irritating solution is injected, often hypertonic dextrose, into painful ligament and tendon attachments and adjacent joint spaces.
In this study, it was aimed to examine the effect of prolotherapy application on pain, neck range of motion and neck disability in women with myofascial pain syndrome.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- UNKNOWN
- Sex
- Female
- Target Recruitment
- 60
- 60 women aged 20-50 years with a diagnosis of myofascial pain syndrome
- Cervical radiculopathy, cervical degeneration, neck surgery or trauma in the last year, injection history for myofascial pain syndrome in the last 6 months, cognitive impairment and fibromyalgia, rheumatoid arthritis, hypothyroidism, diabetes mellitus
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description Control group Local anesthetic and saline injection to the myofascial trigger point Only saline and local anesthetic (lidocaine) Dextrose prolotherapy group Injection of dextrose, local anesthetic and saline to the myofascial trigger point Dextrose, saline and local anesthetic (lidocaine)
- Primary Outcome Measures
Name Time Method Visual Analog Scale First month post-treatment 0-10 cm visual scale (0: no pain, 10: most severe pain)
Neck Disability Index First month post-treatment It measures the functional state of the neck by scoring between 0-5 points according to the severity of pain, consisting of 20 questions.
Neck joint range of motion measurement First month post-treatment Active neck range of motion, which shows the movement of the neck in all directions, is evaluated by goniometric measurement.
- Secondary Outcome Measures
Name Time Method Side effects Through study completion, an average of 6 month. Edema, ecchymosis, hematoma, allergic reaction, exacerbation of pain, systemic or distant side effects
Trial Locations
- Locations (1)
Hatay Mustafa Kemal University, Tayfur Ata Sökmen Faculty of Medicine
🇹🇷Hatay, Turkey